ArticleClinical epigenetics2025

Epigenetic editing and epi-drugs: a combination strategy to simultaneously target KDM4 as a novel anticancer approach.

Federica Sarno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.